Theuer Charles

Oncternal Therapeutics, Inc. · Director

Theuer Charles is listed in filings as Director at Oncternal Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 24, 2024, including 1 public disclosure. Recent filings connect the profile to Oncternal Therapeutics, Inc. (ONCT). The current snapshot covers public activity from Jun 24, 2024. Reported amounts are shown as $17.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.